Misbahudin Rafeeq

19PUBLICATIONS
45CO-AUTHORS
Molecular targetsMedical biochemistry - lipidsCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 10, 2026
Rufigallol attenuates splenic damage caused by STZ by targeting oxidative stress, inflammation, and the apoptosis pathway.

|Aug 27, 2026
Erucic acid arbitrates neuroprotection in streptozotocin-induced memory deficit via improving oxidative stress/neuroinflammatory indicators/cholinergic activity in rodents.

|Jan 05, 2026
Cubebin Niosomal Suspension Attenuates DMBA-Induced Breast Cancer Through the Involvement of Estrogen and Progesterone Receptors and Oxidative/Inflammatory/CA 15-3 Tumor Marker.

Sadaf Jamal Gilani, Ehssan Moglad, Muhammad Afzal

|Nov 17, 2025
Anticancer potential of dietary fiber for colorectal carcinoma: a narrative review.

Muhammad Barkaat Hussain, Abdullah Faisal Albukhari, Misbahuddin Rafeeq

|Jun 27, 2025
Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer's Disease.

Israa J Hakeem, Hadil Alahdal, Hanadi M Baeissa

|Oct 26, 2024
6-Shogaol Abrogates Parkinson's Disease in Rotenone-Induced Rodents: Based on In Silico Study and Inhibiting TNF-α/NF-κB/IL-1β/MAO-B.

Misbahuddin Rafeeq, Fahad A Al-Abbasi, Muhammad Afzal

Pageof 4

Frequent Collaborators

4 joint publications

Sami I Alzrea

4 joint publications

Nadeem Sayyed

4 joint publications

Imran Kazmi

4 joint publications

Hussam Murad